Silva Pharmaceuticals Limited announced earnings results for the second quarter ended December 31, 2019. For the second quarter, the company announced sales was BDT 202.240 million compared to BDT 190.906 million a year ago. Operating income was BDT 42.881 million compared to BDT 43.788 million a year ago. Net income was BDT 35.278 million compared to BDT 33.382 million a year ago. Basic earnings per share was BDT 0.27 compared to BDT 0.26 a year ago. For the half year, sales was BDT 405.585 million compared to BDT 370.581 million a year ago. Operating income was BDT 93.283 million compared to BDT 83.846 million a year ago. Net income was BDT 75.479 million compared to BDT 86.012 million a year ago. Basic earnings per share was BDT 0.57 compared to BDT 0.72 a year ago.